1Blom JW,Doggen CJ,Osanto S,et al.Malignancies,prothombotic mu-tations,and the risk of venous thrombosis[J].JAMA,2005,293(6):715-722.
2Noble S,Pasi J.Epidemiology and pathophysiology of cancer-associatedthrombosis[J].Br J Cancer,2010,102(Suppl 1):S2-S9.
3Agnelli G,Verso M.Management of venous thromboembolism in pa-tients with cancer[J].J Thromb Haemost,2011,9(Suppl 1):316-324.
4Tesselaar ME,Romijn FP,Van Der Linden IK,et al.Microparticle-as-sociated tissue factor activity:a link between cancer and thrombosis?[J].J Thromb Haemost,2007,5(3):520-527.
5Menapace LA,Khorana AA.The role of thromboprophylaxis in cancerpatients:emerging data[J].Curr Opin Hematol,2010,17(5):450-456.
6Suega K,Bakta IM.Correlation between clinical stage of solid tumorand D dimer as a marker of coagulation activation[J].Acta Med In-dones,2011,43(3):162-167.
3Schutgens RE , Esseboom EU , Haas FJ, et al. Usefulness of a semiquantitative D-dimer test for the exclusion of deep venous thrombosis in outpatients[ J]. Am J Med,2002,112(8):617 -621.
4Shitrit D, Heyd J, Raveh D, et al. Diagnostic value of the D-dimer test in deep vein thrombosis: improved results by a new assay method and by using discriminate levels [ J ] . Thromb Res, 2001 ,102(2) :125 - 131.
5Edoute Y , Haim N , Rinkevich D , et al. Cardiac valvular vegetations in cancer patients : a prospective echocardiographic study of 200 patients[ J ]. Am J Med, 1997, 102 (3) :252 -258.
6Greensberg CS, Dcvinc DV, Mc Grac KM, et al. Measurement of plasmafibrin D-dimer levels with the use or a monoclonal antibody coupled Latex bleeding [ J ] . Am J Clin Pathol ,1987,87( 1 ) :94 -96.
